Melbourne, 1 September 2023: Opal Biosciences Limited (“Opal”) today announced its Information Memorandum to raise up to $2.5 million through the issue of 10,000,000 new Shares at $0.25 (25 cents) per share together with one (1) free attaching Option for every one (1) new Share having an exercise price of $0.25 (25 cents) and expiring […]
Melbourne, 9 August 2023: Infectious disease therapy and vaccine development company BioDiem Ltd today announced a change to its board of directors with the retirement of Mr Fergus Mak Po Kan who joined the BioDiem board in September 2021. BioDiem’s chairman Mr Damien Hannes said “We would like to express the company’s gratitude for the […]
